Press Releases

 
Press Releases
  Date Title View
Nov 19, 2014
ALBUQUERQUE, N.M., Nov. 19, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that its Albuquerque, N.M. sterile injectable facility has resumed full manufacturing operations. As previously announced, in September 2014 AMRI identified an environmental deviation in one manufacturing suite as a result of a weather related business interruption...
Nov 5, 2014
ALBANY, N.Y., Nov. 5, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the third quarter ended September 30, 2014. Total revenue for the third quarter of 2014 was $62.5 million, an increase of 3% compared to total revenue of $60.8 million reported in the third quarter of 2013. Total contract ...
Oct 29, 2014
ALBANY, N.Y., Oct. 29, 2014 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer at AMRI, will present at the 2014 Credit Suisse Healthcare Conference on Wednesday, November 12, 2014 at 2:00 p.m. MT. A live audio webcast of the presentation can be accessed...
Oct 24, 2014
ALBANY, N.Y., Oct. 24, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue third quarter financial results before the opening of the U.S. financial markets on Wednesday, November 5, 2014. Following the release of its results, the company will host a conference call and simultaneous audio webcast at 8:30 a.m. ET. The confer...
Sep 4, 2014
ALBANY, N.Y., Sept. 4, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today that it has expanded into the protein market, with an initial focus on protein expression and purification. The global revenue of the total proteomics market is anticipated to grow at a compound annual growth rate of about 4.1% to about $9.2 billion by 20181. AMR...
Aug 26, 2014
ALBANY, N.Y., Aug. 26, 2014 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer at AMRI, will present at the Morgan Stanley Global Healthcare Conference on Monday, September 8, 2014 at 8:45 a.m. ET. A live audio webcast of the presentation can be accessed...
Aug 5, 2014
ALBANY, N.Y., Aug. 5, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the second quarter ended June 30, 2014. Highlights: Second quarter contract revenue of $61.5 million, up 21% from 2013 Second quarter adjusted diluted EPS of $0.22 vs. $0.11 in 2013 Expanded second quarter cont...
Jul 22, 2014
ALBANY, N.Y., July 22, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue second quarter financial results before the opening of the market on Tuesday, August 5, 2014.  Following the release of its results, the company will host a conference call and simultaneous audio webcast at 10:00 a.m. ET. The conference call can be ...
Jul 1, 2014
Albany, NY (July 1, 2014) – AMRI (NASDAQ: AMRI) today announced that it has completed the acquisition of Oso Biopharmaceuticals Manufacturing, a former portfolio company of Altaris Capital Partners, LLC. The transaction is consistent with AMRI’s strategy to be the preeminent supplier of custom and complex drug product development and...
Jun 23, 2014
Albany, NY (June 23, 2014) – AMRI (NASDAQ: AMRI) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR”), in connection with AMRI’s proposed acquisition of Oso Biopharmaceuticals Manufacturing, LLC (“OsoBio”) was terminated by the United States...
Page:
1
... NextLast
= add release to Briefcase